Vasculitis of the mesenteric circulation

Jennette, 2013, 2012 revised International Chapel Hill consensus conference nomenclature of vasculitides, Arthritis Rheum, 65, 1, 10.1002/art.37715 Cohen, 1980, Clinical features, prognosis, and response to treatment in polyarteritis, Mayo Clin Proc, 55, 146 Pagnoux, 2010, Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database, Arthritis Rheum, 62, 616, 10.1002/art.27240 Samson, 2014, Long-term follow-up of a randomized trial on 118 patients with polyarteritis nodosa or microscopic polyangiitis without poor-prognosis factors, Autoimmun Rev, 13, 197, 10.1016/j.autrev.2013.10.001 Selga, 2006, Polyarteritis nodosa when applying the Chapel Hill nomenclature–a descriptive study on ten patients, Rheumatol Oxf, 45, 1276, 10.1093/rheumatology/kel091 McMahon, 1989, Hepatitis B-associated polyarteritis nodosa in Alaskan Eskimos: clinical and epidemiologic features and long-term follow-up, Hepatology, 9, 97, 10.1002/hep.1840090116 Pagnoux, 2005, Med Baltim, 84, 115, 10.1097/01.md.0000158825.87055.0b Levine, 2002, Gastrointestinal involvement in polyarteritis nodosa (1986–2000): presentation and outcomes in 24 patients, Am J Med, 112, 386, 10.1016/S0002-9343(01)01131-7 Bourgarit, 2005, Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: a retrospective analysis of causes and factors predictive of mortality based on 595 patients, Med Baltim, 84, 323, 10.1097/01.md.0000180793.80212.17 Ewald, 1987, Correlation of angiographic abnormalities with disease manifestations and disease severity in polyarteritis nodosa, J Rheumatol, 14, 952 Stanson, 2001, Polyarteritis nodosa: spectrum of angiographic findings, Radiographics, 21, 151, 10.1148/radiographics.21.1.g01ja16151 Ebert, 2008, Gastrointestinal involvement in polyarteritis nodosa, Clin Gastroenterol Hepatol, 6, 960, 10.1016/j.cgh.2008.04.004 Frohnert, 1967, Long-term follow-up study of periarteritis nodosa, Am J Med, 43, 8, 10.1016/0002-9343(67)90144-1 Guillevin, 1996, Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients, Med Baltim, 75, 17, 10.1097/00005792-199601000-00003 Guillevin, 2011, The five-factor score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort, Med Baltim, 90, 19, 10.1097/MD.0b013e318205a4c6 Ribi, 2010, Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: a prospective randomized study of one hundred twenty-four patients, Arthritis Rheum, 62, 1186, 10.1002/art.27340 Guillevin, 2003, Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients, Arthritis Rheum, 49, 93, 10.1002/art.10922 Gayraud, 2001, Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients, Arthritis Rheum, 44, 666, 10.1002/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A Guillevin, 2004, Short-term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus-related polyarteritis nodosa, Arthritis Rheum, 51, 482, 10.1002/art.20401 Stambo, 2004, Coil embolization of multiple hepatic artery aneurysms in a patient with undiagnosed polyarteritis nodosa, J Vasc Surg, 39, 1122, 10.1016/j.jvs.2004.01.018 Battula, 2012, Spontaneous liver haemorrhage and haemobilia as initial presentation of undiagnosed polyarteritis nodosa, Ann R Coll Surg Engl, 94, e163, 10.1308/003588412X13171221590737 Parent, 2010, Spontaneous rupture of hepatic artery aneurysm associated with polyarteritis nodosa, Am Surg, 76, 1416, 10.1177/000313481007601230 Plaut, 1951, Asymptomatic focal arteritis of the appendix; 88 cases, Am J Pathol, 27, 247 Moyana, 1988, Necrotizing arteritis of the vermiform appendix. A clinicopathologic study of 12 cases, Arch Pathol Lab Med, 112, 738 Chen, 1989, Gallbladder vasculitis, J Clin Gastroenterol, 11, 537, 10.1097/00004836-198910000-00009 Alibaz-Oner, 2016, The clinical spectrum of medium-sized vessel vasculitis, Arthritis Care Res Hob, 10.1002/acr.23007 Salvarani, 2010, Localized vasculitis of the gastrointestinal tract: a case series, Rheumatol Oxf, 49, 1326, 10.1093/rheumatology/keq093 Hernandez-Rodriguez, 2014, Single-organ gallbladder vasculitis: characterization and distinction from systemic vasculitis involving the gallbladder. An analysis of 61 patients, Med Baltim, 93, 405, 10.1097/MD.0000000000000205 Hernandez-Rodriguez, 2008, Single-organ vasculitis, Curr Opin Rheumatol, 20, 40, 10.1097/BOR.0b013e3282f176a0 Burke, 1995, Localized vasculitis of the gastrointestinal tract, Am J Surg Pathol, 19, 338, 10.1097/00000478-199503000-00012 Yang, 2005, A nationwide survey on epidemiological characteristics of childhood Henoch-Schonlein purpura in Taiwan, Rheumatol Oxf, 44, 618, 10.1093/rheumatology/keh544 Hocevar, 2014, Incidence of IgA vasculitis in the adult Slovenian population, Br J Dermatol, 171, 524, 10.1111/bjd.12946 Saulsbury, 2002, Epidemiology of henoch-schonlein purpura, Cleve Clin J Med, 69, SII87 Ahn, 2009, Vasculitides of the gastrointestinal tract, Semin Diagn Pathol, 26, 77, 10.1053/j.semdp.2009.06.001 Uppal, 2006, Henoch-Schonlein's purpura in adults versus children/adolescents: a comparative study, Clin Exp Rheumatol, 24, S26 Trapani, 2005, Henoch Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature, Semin Arthritis Rheum, 35, 143, 10.1016/j.semarthrit.2005.08.007 Calvo-Rio, 2016, Relapses in patients with Henoch-Schonlein purpura: analysis of 417 patients from a single center, Med Baltim, 95, e4217, 10.1097/MD.0000000000004217 Chang, 2004, Gastrointestinal manifestations in Henoch-Schonlein purpura: a review of 261 patients, Acta Paediatr, 93, 1427, 10.1111/j.1651-2227.2004.tb02623.x Hong, 2016, Late-onset IgA vasculitis in adult patients exhibits distinct clinical characteristics and outcomes, Clin Exp Rheumatol, 34, S77 Kumon, 1988, A case of vasculitic cholecystitis associated with Schonlein-Henoch purpura in an adult, Gastroenterol Jpn, 23, 68, 10.1007/BF02918859 Branski, 1982, Pancreatitis as a complication of henoch–schonlein purpura, J Pediatr Gastroenterol Nutr, 1, 275, 10.1097/00005176-198201020-00020 Mills, 1990, The American college of rheumatology 1990 criteria for the classification of henoch-schonlein purpura, Arthritis Rheum, 33, 1114, 10.1002/art.1780330809 Calvino, 2001, Henoch-Schonlein purpura in children from northwestern Spain: a 20-year epidemiologic and clinical study, Med Baltim, 80, 279, 10.1097/00005792-200109000-00001 Davin, 2001, What is the difference between IgA nephropathy and Henoch-Schonlein purpura nephritis?, Kidney Int, 59, 823, 10.1046/j.1523-1755.2001.059003823.x Preud'Homme, 2006, Use of wireless capsule endoscopy in the management of severe Henoch-Schonlein purpura, Pediatrics, 118, e904, 10.1542/peds.2005-3111 Li, 2014, The diagnostic usefulness of video capsule endoscopy in adolescent immunoglobulin A vasculitis (Henoch-Schonlein purpura), J Nippon Med Sch, 81, 114, 10.1272/jnms.81.114 Goldstein, 1992, Long-term follow-up of childhood Henoch-Schonlein nephritis, Lancet, 339, 280, 10.1016/0140-6736(92)91341-5 Kang, 2014, Differences in clinical manifestations and outcomes between adult and child patients with Henoch-Schonlein purpura, J Korean Med Sci, 29, 198, 10.3346/jkms.2014.29.2.198 Pillebout, 2002, Henoch-Schonlein Purpura in adults: outcome and prognostic factors, J Am Soc Nephrol, 13, 1271, 10.1097/01.ASN.0000013883.99976.22 Rigante, 2005, Predictive factors of renal involvement or relapsing disease in children with Henoch-Schonlein purpura, Rheumatol Int, 25, 45, 10.1007/s00296-004-0452-2 Prais, 2007, Recurrent Henoch-Schonlein purpura in children, J Clin Rheumatol, 13, 25, 10.1097/01.rhu.0000255692.46165.19 Blanco, 1997, Henoch-Schonlein purpura in adulthood and childhood: two different expressions of the same syndrome, Arthritis Rheum, 40, 859, 10.1002/art.1780400513 Padeh, 2000, Successful treatment of chronic Henoch-Schonlein purpura with colchicine and aspirin, Isr Med Assoc J, 2, 482 Bech, 2013, Dapsone for the treatment of chronic IgA vasculitis (Henoch-Schonlein), Neth J Med, 71, 220 Wu, 2014, Add-on therapy with montelukast in the treatment of Henoch-Schonlein purpura, Pediatr Int, 56, 315, 10.1111/ped.12271 Niaudet, 1998, Methylprednisolone pulse therapy in the treatment of severe forms of Schonlein-Henoch purpura nephritis, Pediatr Nephrol, 12, 238, 10.1007/s004670050446 Szer, 1999, Gastrointestinal and renal involvement in vasculitis: management strategies in Henoch-Schonlein purpura, Cleve Clin J Med, 66, 312, 10.3949/ccjm.66.5.312 Weiss, 2007, Effects of corticosteroid on Henoch-Schonlein purpura: a systematic review, Pediatrics, 120, 1079, 10.1542/peds.2007-0667 Nam, 2014, Gastrointestinal bleeding in adult patients with Henoch-Schonlein purpura, Endoscopy, 46, 981, 10.1055/s-0034-1377757 Pillebout, 2010, Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adult patients with severe Henoch Schonlein Purpura, Kidney Int, 78, 495, 10.1038/ki.2010.150 Shin, 2005, Can azathioprine and steroids alter the progression of severe Henoch-Schonlein nephritis in children?, Pediatr Nephrol, 20, 1087, 10.1007/s00467-005-1869-x Fotis, 2016, Azathioprine therapy for steroid-resistant Henoch-Schonlein purpura: a report of 6 cases, Pediatr Rheumatol Online J, 14, 37, 10.1186/s12969-016-0100-x Ren, 2012, The combination of mycophenolate mofetil with corticosteroids induces remission of Henoch-Schonlein purpura nephritis, Am J Nephrol, 36, 271, 10.1159/000341914 Pillebout, 2011, Successful outcome using rituximab as the only immunomodulation in Henoch-Schonlein purpura: case report, Nephrol Dial Transpl, 26, 2044, 10.1093/ndt/gfr137 Ishiguro, 2013, Rituximab treatment for adult purpura nephritis with nephrotic syndrome, Intern Med, 52, 1079, 10.2169/internalmedicine.52.9325 Mohammad, 2009, Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa, Rheumatol Oxf, 48, 1560, 10.1093/rheumatology/kep304 Watts, 2009, Prevalence and incidence of Wegener's granulomatosis in the UK general practice research database, Arthritis Rheum, 61, 1412, 10.1002/art.24544 Hoffman, 1992, Wegener granulomatosis: an analysis of 158 patients, Ann Intern Med, 116, 488, 10.7326/0003-4819-116-6-488 Steele, 2001, Acute upper gastrointestinal haemorrhage and colitis: an unusual presentation of Wegener's granulomatosis, Eur J Gastroenterol Hepatol, 13, 993, 10.1097/00042737-200108000-00023 Kim, 2000, Churg-Strauss syndrome with perforating ulcers of the colon, J Korean Med Sci, 15, 585, 10.3346/jkms.2000.15.5.585 Jones, 2010, Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis, N Engl J Med, 363, 211, 10.1056/NEJMoa0909169 Stone, 2010, Rituximab versus cyclophosphamide for ANCA-associated vasculitis, N Engl J Med, 363, 221, 10.1056/NEJMoa0909905 Mohammad, 2016, Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss), Ann Rheum Dis, 75, 396, 10.1136/annrheumdis-2014-206095 Kerr, 1994, Takayasu arteritis, Ann Intern Med, 120, 919, 10.7326/0003-4819-120-11-199406010-00004 Watts, 2009, The epidemiology of Takayasu arteritis in the UK, Rheumatol Oxf, 48, 1008, 10.1093/rheumatology/kep153 Arend, 1990, The American college of rheumatology 1990 criteria for the classification of Takayasu arteritis, Arthritis Rheum, 33, 1129, 10.1002/art.1780330811 Schmidt, 2013, Diagnostic features, treatment, and outcomes of Takayasu arteritis in a US cohort of 126 patients, Mayo Clin Proc, 88, 822, 10.1016/j.mayocp.2013.04.025 Misra, 2016, Takayasu arteritis (TA) first presenting with intestinal ischemia: a case report and review of gastrointestinal tract involvement (ischemic and non-ischemic) associated with TA, Rheumatol Int Setty, 2016, Clinical, angiographic profile and percutaneous endovascular management of Takayasu's arteritis - a single centre experience, Int J Cardiol, 220, 924, 10.1016/j.ijcard.2016.06.194 Hoffman, 2004, Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis, Arthritis Rheum, 50, 2296, 10.1002/art.20300 Della Rossa, 2005, Two Takayasu arteritis patients successfully treated with infliximab: a potential disease-modifying agent?, Rheumatol Oxf, 44, 1074, 10.1093/rheumatology/keh661 Salvarani, 2012, Tocilizumab: a novel therapy for patients with large-vessel vasculitis, Rheumatol Oxf, 51, 151, 10.1093/rheumatology/ker296 Unizony, 2012, Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica, Arthritis Care Res Hob, 64, 1720, 10.1002/acr.21750 Pons-Estel, 2010, Understanding the epidemiology and progression of systemic lupus erythematosus, Semin Arthritis Rheum, 39, 257, 10.1016/j.semarthrit.2008.10.007 Danchenko, 2006, Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden, Lupus, 15, 308, 10.1191/0961203306lu2305xx Ju, 2009, Lupus mesenteric vasculitis can cause acute abdominal pain in patients with SLE, Nat Rev Rheumatol, 5, 273, 10.1038/nrrheum.2009.53 Lian, 2003, Reversible acute gastrointestinal syndrome associated with active systemic lupus erythematosus in patients admitted to hospital, Lupus, 12, 612, 10.1191/0961203303lu433oa Ko, 1997, CT findings at lupus mesenteric vasculitis, Acta Radiol, 38, 115, 10.3109/02841859709171253 Zizic, 1982, Acute abdominal complications of systemic lupus erythematosus and polyarteritis nodosa, Am J Med, 73, 525, 10.1016/0002-9343(82)90331-X Sultan, 1999, A review of gastrointestinal manifestations of systemic lupus erythematosus, Rheumatol Oxf, 38, 917, 10.1093/rheumatology/38.10.917 Grimbacher, 1998, Successful treatment of gastrointestinal vasculitis due to systemic lupus erythematosus with intravenous pulse cyclophosphamide: a clinical case report and review of the literature, Br J Rheumatol, 37, 1023, 10.1093/rheumatology/37.9.1023 Waite, 2007, Severe gastrointestinal involvement in systemic lupus erythematosus treated with rituximab and cyclophosphamide (B-cell depletion therapy), Lupus, 16, 841, 10.1177/0961203307081118 Makol, 2015, Rheumatoid vasculitis: an update, Curr Opin Rheumatol, 27, 63, 10.1097/BOR.0000000000000126 Ntatsaki, 2014, Systemic rheumatoid vasculitis in the era of modern immunosuppressive therapy, Rheumatol Oxf, 53, 145, 10.1093/rheumatology/ket326 Voskuyl, 1996, Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study, Ann Rheum Dis, 55, 190, 10.1136/ard.55.3.190 Watts, 1994, The incidence of rheumatoid vasculitis in the Norwich Health Authority, Br J Rheumatol, 33, 832, 10.1093/rheumatology/33.9.832 Makol, 2014, Vasculitis associated with rheumatoid arthritis: a case-control study, Rheumatol Oxf, 53, 890, 10.1093/rheumatology/ket475 Scott, 1984, Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis, Am J Med, 76, 377, 10.1016/0002-9343(84)90654-5 Puechal, 2012, Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: results from the AutoImmunity and Rituximab Registry, Arthritis Care Res Hob, 64, 331, 10.1002/acr.20689 Yurdakul, 2004, Behçet syndrome, Curr Opin Rheumatol, 16, 38, 10.1097/00002281-200401000-00008 Calamia, 2009, Epidemiology and clinical characteristics of Behçet’s disease in the US: a population-based study, Arthritis Rheum, 61, 600, 10.1002/art.24423 Mohammad, 2013, Incidence, prevalence and clinical characteristics of Behcet's disease in southern Sweden, Rheumatol Oxf, 52, 304, 10.1093/rheumatology/kes249 International Study Group for Behcets’s Diease, 1990, Criteria for diagnosis of Behcet's disease, Lancet, 335, 1078 Seyahi, 2016, Behcet's disease: how to diagnose and treat vascular involvement, Best Pract Res Clin Rheum, 30, 279, 10.1016/j.berh.2016.08.002 Cheon, 2015, An update on the diagnosis, treatment, and prognosis of intestinal Behcet's disease, Curr Opin Rheum, 27, 24, 10.1097/BOR.0000000000000125 Park, 1993, Clinical study on death in Behcet's disease, J Korean Med Sci, 8, 241, 10.3346/jkms.1993.8.4.241 Saadoun, 2010, Mortality in Behcet's disease, Arthritis Rheum, 62, 2806, 10.1002/art.27568 Ward, 2003, Gastrointestinal disease in Behcet's disease, Adv Exp Med Biol, 528, 459, 10.1007/0-306-48382-3_93 Hisamatsu, 2014, The 2nd Edition of consensus statements for the diagnosis and management of intestinal Behcet's disease: indication of anti-TNF alpha monoclonal antibodies, J Gastroenterol, 49, 156, 10.1007/s00535-013-0872-4 Tuzun, 2012, Management and prognosis of nonpulmonary large arterial disease in patients with Behcet's disease, J Vasc Surg, 55, 157, 10.1016/j.jvs.2011.07.049 Jachiet, 2015, The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: data from a French nationwide study of fifty-seven patients, Arthritis Rheumatol, 67, 527, 10.1002/art.38956 Zeiss, 1980, A hypocomplementemic vasculitic urticarial syndrome. Report of four new cases and definition of the disease, Am J Med, 68, 867, 10.1016/0002-9343(80)90216-8